Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes

Journal of Cellular Physiology

Volumn 172, Issue 3, 1997, Pages 275-283

  Montrose Rafizadeh, Chahrzad ^a   Yang, Huan ^a   Wang, Yihong ^a   Roth, Jesse ^b   Montrose, Marshall H ^b   Adams, Lisa G ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCAGON RECEPTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL STRAIN 3T3; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN RELEASE; LIPOLYSIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ADIPOCYTES; ANIMALS; BINDING, COMPETITIVE; CALCIUM; CHO CELLS; CRICETINAE; CYCLIC AMP; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; LIPOLYSIS; MICE; PEPTIDE FRAGMENTS; PEPTIDES; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; VENOMS;

ANIMALIA;

EID: 0030884317     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L     Document Type: Article

References (41)

1. Ahren, B. (1995) Antidiabetogenic action of truncated glucagon-like peptide-1 in mice. Endocrine, 3:367-369.
2. Boobis, L.H., and Maughan, R.J. (1983) A simple one step enzymatic fluorimetric method for the determination of glycerol in 20 μl of plasma. Clin. Chim. Acta, 132:173-179.
3. Bullock, B.P., Heller, R.S., and Habener, J.F. (1996) Tissue distribution of messenger ribonuleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology, 137:2968-2978.
4. Cheeseman, C.I., and Tsang, R. (1996) The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport. Am. J. Physiol., 271:G477-G482.
5. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18:5294-5299.
6. D'Alessio, D.A., Kahn, S.E., Leusner, C.R., and Ensinck, J.W. (1994) Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J. Clin. Invest., 93:2263-2266.
7. D'Alessio, D.A., Prigeon, R.L., and Ensinck, J.W. (1995) Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes, a physiological role of glucagon-like peptide I. Diabetes, 44:1433-1437.
8. Delgado, E., Luque, M.A., Alcantara, A., Trapote, M.A., Clemente, F., Galera, C., Valverde, I., and Villanueva-Penacarrillo, M. L. (1995) Glucagon-like peptide-1 binding to rat skeletal muscle. Peptides, 16:225-229.
9. Drucker, D.J., Ehrlich, P., Asa, S.L., and Brubaker, P.L. (1996) Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc. Natl. Acad. Sci. U.S.A., 93:7911-7916.
10. Egan, J.M., Montrose-Rafizadeh, C., Wang, Y., Bernier, M., and Roth, J. (1994) Glucagon-like peptide-1 (7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: One of several potential extrapancreatic sites of GLP-1 action. Endocrinology, 135:2070-2075.
11. Fehmann, H.C., Goke, R., and Goke, B. (1992) At the cutting edge: Glucagon-like peptide-1 (7-37)/(7-36) amide is a new incretin. Mol. Cell. Endocrinol., 85:C39-C44.
12. Fehmann, H.C., Goke, R., and Goke, B. (1995) Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr. Rev., 16(3):390-410.
13. Furnsinn, C., Ebner, K., and Waldhausl, W. (1995) Failure of GLP-1 (7-36) amide to affect glycogenesis in rat skeletal muscle. Diabetologia, 38:864-867.
14. Gefel, D., Hendrick, G.K., Mojsov, S., Habener, J.F., and Weir, G.C. (1990) Glucagon-like peptide-I analogs: Effects on insulin secretion and adenosine 3′,5′-cyclic monophosphate formation. Endocrinology, 126:2164-2168.
15. Glisin, V., Crkvenjadov, R., and Byrus, C. (1974) Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry, 13:2633-2637.
16. Gutniak, M., Orskov, C., Holst, J.J., Ahren, B., and Efendic, S. (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med., 326:1316-1622.
17. Hvidberg, A., Toft-Nielsen, M.-b., Hilsted, J., Orskov, C., and Holst, J.J. (1994) Effect of glucagon-like peptide-1 (proglucagon 78-107 amide) on hepatic glucose production in healthy man. Metabolism, 43:104-108.
18. Komatsu, R., Matsuyama, T., Namba, M., Watanabe, N., Itoh, H., Kono, N., and Tarui, S. (1989) Glucagonostatic and insulinotropic action of glucagon-like peptide-1 (7-36) amide. Diabetes, 38:902-905.
19. Lu, M., Wheeler, M. B., Leng, X.-H., and Boyd III, A.E. (1993) The role of the free cytosolic calcium level in B-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide 1-(7-37). Endocrinology, 132:94-100.
20. Merida E., Delgado, E., Molina, L.M., Villanueva-Penacarrillo, M.L., and Valverde, I. (1993) Presence of glucagon and glucagon-like peptide-1-(7-36) amide receptors in solubilized membranes of human adipose tissue. J. Clin. Endocrinol. Metab., 77:1654-1657.
21. Mojsov, S., Heinrich, G., Wilson, I.B., Ravazzola, M., Orci, L., and Habener, J.F. (1986) Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-transcriptional processing. J. Biol. Chem., 261:11880-11889.
22. Montrose-Rafizadeh, C., Egan, J.M., and Roth, J. (1994) Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: Mechanisms of action. Endocrinology, 135(2):589-594.
23. Nathan, D.M., Schreiber, E., Fogel, H., Mojsov, S., and Habener, J.F. (1992) Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects. Diabetes Care, 15:270-276.
24. Nauck, M.A., Kleine, N., Orskov, C., Host, J.J., Willms, B., and Creutzfeldt W. (1993) Normalization of fasting hyperglycaemia by exogeneous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 36:741-744.
25. Nudel, U., Zakut, R., Shani, R., Neuman, S., Levy, Z., and Yaffe, D. (1983) The nucleotide sequence of rat cytoplasmic B-actin gene. Nucleic Acids Res., 11:1759-1762.
26. Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G., Mullis, K.B., and Erlich, H.A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239:487-491.
27. 2+ response of carotid cheoreceptor cells to hypoxia. Am. J. Physiol., 268 (5 pt. 1):L801-808.
28. Svoboda M., Ciccarelli, E., Tastenoy, M., Cauvin, A., Stievenart, M., and Christophe, J. (1993) Small introns in a hepatic cDNA encoding a new glucagon-like peptide 1-type receptor. Biochem. Biophys. Res. Commun., 191(2):479-486.
29. Svoboda, M., Tastenoy, M., Vertongen, P., and Robberecht, P. (1994) Relative quantitative analysis of glucaton receptor mRNA in rat tissues. Mol. Cell. Endocrinol., 105:131-137.
30. Thorens, B. (1992) Expression cloning of the pancreatic B cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. U.S.A., 89:8641-8645.
31. Toft-Nielsen, M.-b., Madsbad, S., and Holst, J.J. (1996) The effect of glucagon-like peptide I (GLP-1) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones. Diabetes, 45:552-556.
32. Tominaga, M., Ikezawa, Y., Yamatani, K., Manaka, H., Egachi, H., Daimon, M., and Sasaki, H. (1996) Effect of glucagon-like peptide-17-37 on in vivo insulin sensitivity of rats. Diabetes, 45:153A.
33. Usdin, T.B., Mezey, E., Button, D.C., Brownstein, M.J., and Bonner, T.I. (1993) Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology, 133:2861-2870.
34. Valverde, I., Morales, M., Clemente, F., Lopez-Delgado, M.I., Delgado, E., Perea, A., and Villanueva-Penacarrillo, M.L. (1994) Glucagon-like peptide 1: A potent glycogenic hormone. FEBS Lett., 349:313-316.
35. Villanueva-Penacarrillo, M.L., Alcantara, A.I., Clemente, F., Delgado, E., and Valverde, I. (1994) Potent glycogenic effect of GLP-1 (7-36) amide in rat skeletal muscle. Diabetologia, 37:1163-1166.
36. Villanueva-Penacarrillo, M.L., Delgado, E., Trapote, M.A., Alcantara, A., Clemente, F., Luque, M.A., Perea, A., and Valverde, I. (1995) Glucagon-like peptide-1 binding to rat hepatic membranes. J. Endocrinol., 146(1):183-189.
37. Weir, G.C., Mojsov, S., Hendrick, G.K., and Habener, J.F. (1989) Glucagon-like peptide I (7-37) action on the endocrine pancreas. Diabetes, 38:338-342.
38. Wheeler, M.B., Ming, L., Dillon, J.S., Leng, X.-H., Chen, C., and Boyd III, A.E. (1993) Functional expression of rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology, 133:57-62.
39. Widmann, C., Burki, E., Dolci, W., and Thorens, B. (1994) Signal transduction by the cloned glucagon-like peptide-1 receptor: Comparison with signaling by the endogenous receptors of B cell lines. Mol. Pharmacol., 45:1029-1035.
40. Yamato, E., Noma, Y., Tahara, Y., Ikegami, H., Yamamoto, Y., Cha, T., Yoneda, H., Ogihara, T., Ohboshi, C., Hirota, M., and Shima K (1990) Suppression of synthesis and release of glucagon by glucagon-like peptide-1 (7-36) amide without effect on mRNA level in isolated rat islets. Biochem. Biophys. Res. Commun., 167:431-437.
41. Yang, H., Egan, J.M., Wang, Y., Taha, C., Moyes, C., Klip, A., and Montrose-Rafizadeh, C. (1996) Muscle and pancreas express distinct GLP-1 receptors. Tenth Int. Congr. Endocrinol., 1:356.